Efficacy and Safety of Avatrombopag for Treating TCP in HBV-ACLF Patients Receiving ALSS Treatment
Status:
Recruiting
Trial end date:
2024-04-30
Target enrollment:
Participant gender:
Summary
This study aims to investigate the efficacy and safety of avatrombopag for treating
thrombocytopenia in hepatitis b virus related acute-on-chronic liver failure patients
receiving artificial liver support system treatment.